University of Pittsburgh Medical Center | ClinicalTrials HQ

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy	Skin and Connective Tissue Diseases, antisynthetase syndrome, connective tissue disorder, dermatomyositis, immune-mediated necrotizing myopathy, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder	Enrolling by invitation	Phase 3	2026-09-21		NCT05979441
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)	Infections, Respiration Disorders, adult acute respiratory distress syndrome, lung disorder, respiratory failure, respiratory system disorder	Recruiting	Phase 2	2026-09-10		NCT05947955
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis	Skin and Connective Tissue Diseases, cardiovascular disorder, connective tissue disorder, diffuse scleroderma, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, skin disorder, systemic sclerosis, vascular disorder	Recruiting	Phase 2	2026-08-14		NCT03630211
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes	Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms	Recruiting	Not stated	2026-08-07		NCT06399302
Ceribell Delirium Monitor Outcomes Pilot Study	Confusion, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cognitive disorder, delirium, nervous system disorder, psychiatric disorder	Recruiting	Not applicable	2026-07-22		NCT07449416
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )	Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease	Active, not recruiting	Phase 3	2026-07-02		NCT04849728
Phase 2 Study of Rapcabtagene Autoleucel in Myositis	Skin and Connective Tissue Diseases, acquired idiopathic inflammatory myopathy, connective tissue disorder, dermatomyositis, interstitial lung disease, lung disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, respiratory system disorder, skin disorder	Active, not recruiting	Phase 2	2026-06-23		NCT06665256
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder	Recruiting	Phase 1 / Phase 2	2026-04-01		NCT04486352
Cardiogenic Shock Working Group Registry	Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, heart failure, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder	Recruiting	Not stated	2025-06-06		NCT04682483
Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis	arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder	Active, not recruiting	Phase 3	2025-04-23		NCT04440189